Brief by Shorts91 Newsdesk / 07:09pm on 04 Oct 2024,Friday Health & Wellness
Researchers at the University of Oxford are developing the world’s first ovarian cancer vaccine, OvarianVax, which teaches the immune system to attack early-stage ovarian cancer cells. This breakthrough, funded by Cancer Research UK, could potentially eradicate the disease, similar to the success of the HPV vaccine in preventing cervical cancer. The vaccine is being developed for clinical trials on women with BRCA gene mutations, who are at higher risk. Researchers hope to see the vaccine's impact in as soon as five years.
